Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'.
作者信息
Martora Fabrizio, Villani Alessia, Marasca Claudio, Fabbrocini Gabriella, Potestio Luca
机构信息
Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e43-e44. doi: 10.1111/jdv.18531. Epub 2022 Aug 20.
Abstract
摘要
相似文献
1
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'.新型冠状病毒2疫苗接种后的皮肤反应 对“新型冠状病毒2疫苗加强针后的皮肤不良反应：一项真实世界多中心经验”的回复
J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e43-e44. doi: 10.1111/jdv.18531. Epub 2022 Aug 20.
2
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience.新型冠状病毒2型疫苗加强针接种后的皮肤不良反应：一项真实世界多中心经验
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):e876-e879. doi: 10.1111/jdv.18386. Epub 2022 Jul 10.
3
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.一项在已接种 SARS-CoV-2 疫苗的≥75 岁成年人中评估不同 COVID-19 疫苗免疫原性和反应原性的多国、2 期、随机、自适应方案：在 VACCELERATE 网络内开展的一项试验。
Trials. 2022 Oct 8;23(1):865. doi: 10.1186/s13063-022-06791-y.
4
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.新型冠状病毒 ARCoV mRNA 疫苗在中国成年人中的安全性和免疫原性：一项随机、双盲、安慰剂对照、1 期临床试验。
Lancet Microbe. 2022 Mar;3(3):e193-e202. doi: 10.1016/S2666-5247(21)00280-9. Epub 2022 Jan 24.
5
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial.SpikoGen®作为同源和异源加强疫苗的免疫原性和安全性：一项随机安慰剂对照试验。
Immunology. 2022 Nov;167(3):340-353. doi: 10.1111/imm.13540. Epub 2022 Jul 13.
6
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.≥65 岁成年人中同时接种高剂量四价流感疫苗和 mRNA-1273 新冠疫苗第三针的安全性和免疫原性：一项 2 期、随机、开放标签研究。
Lancet Respir Med. 2022 Apr;10(4):392-402. doi: 10.1016/S2213-2600(21)00557-9. Epub 2022 Feb 1.
7
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial.mRNA-1273 加强针后的 SARS-CoV-2 免疫反应：一项开放标签的 2 期临床试验。
Nat Med. 2022 May;28(5):1042-1049. doi: 10.1038/s41591-022-01739-w. Epub 2022 Mar 3.
8
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
9
Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity.3例接种新型冠状病毒mRNA疫苗后的皮肤不良反应：严重程度不一。
CMAJ. 2022 Jun 13;194(23):E807-E811. doi: 10.1503/cmaj.220435.
10
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.SARS-CoV-2 疫苗相关皮肤表现：系统综述。
Int J Dermatol. 2022 Oct;61(10):1187-1204. doi: 10.1111/ijd.16063. Epub 2022 Feb 9.
引用本文的文献
1
Factors Associated with Treatment Satisfaction in Korean Patients with Psoriasis.韩国银屑病患者治疗满意度的相关因素
Patient Prefer Adherence. 2024 Oct 4;18:2093-2105. doi: 10.2147/PPA.S485512. eCollection 2024.
2
Emerging Role of Biologic Drugs Targeting IL-17 and IL-23: Pityriasis Rubra Pilaris.靶向IL-17和IL-23的生物药物的新作用：红皮病型毛发红糠疹
Life (Basel). 2024 Jul 24;14(8):923. doi: 10.3390/life14080923.
3
Rare COVID-19 vaccine side effects got lost in the shuffle. Primary cutaneous lymphomas following COVID-19 vaccination: a systematic review.罕见的新冠疫苗副作用在混乱中被忽视了。新冠疫苗接种后的原发性皮肤淋巴瘤：一项系统综述。
Front Med (Lausanne). 2024 Apr 10;11:1325478. doi: 10.3389/fmed.2024.1325478. eCollection 2024.
4
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials.白细胞介素23/17轴在银屑病治疗中的作用：临床试验综述
Clin Cosmet Investig Dermatol. 2024 Apr 10;17:829-842. doi: 10.2147/CCID.S462797. eCollection 2024.
5
The Past, the Present and the Future of Teledermatology: A Narrative Review.远程皮肤病学的过去、现在与未来：一篇叙述性综述
Clin Cosmet Investig Dermatol. 2024 Mar 21;17:717-723. doi: 10.2147/CCID.S462799. eCollection 2024.
6
Biologics protect psoriasis patients from being exacerbated by COVID-19 infection.生物制剂可保护银屑病患者免受新冠病毒感染的病情加重影响。
Heliyon. 2024 Jan 14;10(2):e24534. doi: 10.1016/j.heliyon.2024.e24534. eCollection 2024 Jan 30.
7
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.新型冠状病毒肺炎疫苗接种后玫瑰糠疹及玫瑰糠疹样皮疹：一项叙述性综述
Clin Cosmet Investig Dermatol. 2024 Jan 8;17:51-57. doi: 10.2147/CCID.S447834. eCollection 2024.
8
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab.司库奇尤单抗成功治疗红皮病型银屑病1例
Clin Cosmet Investig Dermatol. 2023 Dec 5;16:3503-3507. doi: 10.2147/CCID.S447123. eCollection 2023.
9
Herpes Zoster and COVID-19 Vaccination: A Narrative Review.带状疱疹与新冠病毒疫苗接种：一篇叙述性综述
Clin Cosmet Investig Dermatol. 2023 Nov 16;16:3323-3331. doi: 10.2147/CCID.S441898. eCollection 2023.
10
Covid-19, leukemia, and secondary malignancies of the skin - is there a connection: a case report and literature analysis.新型冠状病毒肺炎、白血病与皮肤继发性恶性肿瘤——它们之间有关联吗：一例病例报告及文献分析
Front Oncol. 2023 Oct 27;13:1265479. doi: 10.3389/fonc.2023.1265479. eCollection 2023.
Zotero 插件